The 3,002 incidents occurring in CY 2015 involved 1,095 different pharmaceutical products. The number of products found in a single incident ranged from one drug to thirty-seven different drugs. Once again, pharmaceuticals in every therapeutic category were copied by criminal organizations.
CIS data revealed that medicines in the genito-urinary, anti-infectives and central nervous system (CNS) therapeutic categories contained the largest number of counterfeit incidents. These three categories were seen as having drugs which were the most frequently targeted by individuals engaged in pharmaceutical counterfeiting.
While the ranking of the top therapeutic categories were relatively unchanged, the Institute has noted seven therapeutic categories that have had a percentage increase on a year-to-year basis. Specifically, the genito-urinary therapeutic category led with the largest percentage increase at sixty-five percent (+65%). Categories with percentage increases also included dermatologicals (+57%), cytostatics (+29%), cardiovascular (+29%), respiratory (+28%), CNS (+11%), and alimentary (+4%).